Quality of life in irritable bowel syndrome: measurement techniques and relevance of current knowledge

References

• Constitution of the VVorld Health Organization. Handbook of basic documents. 5th ed. World Health Organization, Palais des Nations, Geneva, Switzerland (1952).
   Google Scholar
• Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann. Intern. Med 118(8), 622–629 (1993).
   Google Scholar
• ••Review dealing with basic principles ofHRQOL measurement.
   Google Scholar
• Thompson WG, Longstreth GF, Drossman DA, Heaton KVV, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 45\(Suppl. 2), 1143–47 (1999).
   Google Scholar
• ••Current diagnostic criteria for IBS - theROME II criteria.
   Google Scholar
• Agreus L, Svärdsudd K, Nyren 0, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 109(3), 671–680 (1995).
   Google Scholar
• •Swedish study on the epidemiology of functional GI disorders in a well-defined geographical area.
   Google Scholar
• Drossman DA, Li Z, Andruzzi E et a/. US householder survey of functional gastrointestinal disorders. Prevalence, sociodemography and health impact. Dig Dis. Sd. 38(9), 1569–1580 (1993).
   Google Scholar
• Longstreth GF, Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics and clinical correlates. Dig. Dis. Sc]. 38(9), 1581–1589 (1993).
   Google Scholar
• Talley NJ, Boyce P, Jones M. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population. Gut 42(5), 690–695 (1998).
   PubMed Web of Science ®Google Scholar
• Heaton KVV, O'Donnell LJ, Braddon FE, Mountford RA, Hughes AO, Cripps PJ. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology 102(6), 1962–1967 (1992).
   PubMed Web of Science ®Google Scholar
• Talley NJ, Boyce PM, Jones M. Predictors of healthcare seeking for irritable bowel syndrome: a population based study. Gut 41(3), 394–398 (1997).
   PubMed Web of Science ®Google Scholar
• Thompson WG, Heaton KW Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics and referral. Gut 46(1), 78–82 (2000) .
   PubMed Web of Science ®Google Scholar
• Harvey RF, Salih SY, Read AE. Organic and functional disorders in 2000 gastroenterology out-patients. Lancet 1(8325), 632–634 (1983).
   Google Scholar
• El-Serag FIB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 16(6), 1171–1185 (2002).
   PubMed Web of Science ®Google Scholar
• •Systematic review of the literature on HRQOL in B3S.
   Google Scholar
• Lea R, Whorwell PJ. Quality of life in irritable bowel syndrome. PharmacoEconomics 19(6), 643–653 (2001).
   PubMed Web of Science ®Google Scholar
• •Overview of the current knowledge of HRQOL measurement in IBS.
   Google Scholar
• Luscombe FA. Health-related quality of life and associated psychosocial factors in irritable bowel syndrome: a review. Qual. Life Res 9(2), 161–176 (2000).
   PubMed Web of Science ®Google Scholar
• •Well-written review of HRQOL and psychosocial factors in B3S.
   Google Scholar
• Veldhuyzen van Zanten SJ, Talley NJ, Bytzer P, Klein KB, Whorwell PJ, Zinsmeister AR. Design of treatment trials for functional gastrointestinal disorders. Gut 45 (Suppl. 2), 1169–1177 (1999).
   Google Scholar
• •Recommendations regarding how to perform treatment trials in functional GI disorders.
   Google Scholar
• Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. B,r. Dis Sc]. 34(9), 1379–1386 (1989).
   Google Scholar
• Borgaonkar MR, Irvine EJ. Quality of life measurement in gastrointestinal and liver disorders. Gut 47(3), 444–454 (2000).
   PubMed Web of Science ®Google Scholar
• Eisen GM, Locke GR 3rd, Provenzale D. Health-related quality of life: a primer for gastroenterologists. Am J. Gastroenterol. 94(8), 2017–2021 (1999).
   Google Scholar
• •Easy-to-understand overview of HRQOL in gastroenterology.
   Google Scholar
• Sullivan M. Quality of life assessment in medicine. Concepts, definitions, purposes and basic tools. Nord. Bydriatry 46,79–83 (1992).
   Google Scholar
• Ware JE Jr. Standards for validating health measures: definition and content. J.Chronic Dis. 40(6), 473–480 (1987).
   PubMedGoogle Scholar
• Patrick DL, Erickson P. Assessing health- related quality of life for clinical decision-making. In: Quality of life Assessment —Key Issues in the 1990s. Walker SR, Rosser PM (Ed.). Kluwer Academic Publishers, Lancaster, UK, 11–63 (1993).
   Google Scholar
• Creed F, Ratcliffe J, Fernandez L eta]. Health-related quality of life and healthcare costs in severe, refractory irritable bowel syndrome. Ann. Intern. Med 134(9 Pt 2), 860–868 (2001).
   Google Scholar
• Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Castmenterology119(3), 654–660 (2000).
   PubMed Web of Science ®Google Scholar
• •Important paper, where HRQOL is compared between IBS and other chronic conditions.
   Google Scholar
• Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilimtion and quality of life. Aliment Pharmacol The]: 11(3), 553–559 (1997).
   PubMed Web of Science ®Google Scholar
• •Study investigating the importance of perceived severity of GI symptoms, HRQOL and costs in IBS patients.
   Google Scholar
• Hahn BA, Yan S, Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion 60(1), 77–81 (1999).
   PubMed Web of Science ®Google Scholar
• Lee OY, Fitzgerald LZ, Naliboff B etal. Impact of advertisement and clinic populations in symptoms and perception of irritable bowel syndrome. Aliment Pharmacol Ther 13(12), 1631–1638 (1999).
   PubMed Web of Science ®Google Scholar
• O'Keefe EA, Talley NJ, Zinsmeister AR, Jacobsen SJ. Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J. Cemntol A. Biol. Li. Med Li 50(4), M184-189 (1995).
   Google Scholar
• •Paper dealing with an often neglected area of research — the impact of functional GI symptoms in the elderly.
   Google Scholar
• Patrick DL, Drossman DA, Frederick TO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig. Dis. Sci 43(2), 400–411 (1998). •Initial validation of the IBS-QOL questionnaire.
   Google Scholar
• Schmulson M, Lee OY, Chang L, Naliboff B, Mayer EA. Symptom differences in moderate to severe IBS patients based on predominant bowel habit. Am. J. Castmenterol. 94(10), 2929–2935 (1999).
   Google Scholar
• Whitehead WE, Burnett CK, Cook EW 3rd, Taub E. Impact of irritable bowel syndrome on quality of life. Dig. Dis. Li 41(11), 2248–2253 (1996).
   Google Scholar
• ••First paper that assessed HRQOL inpatients and nonconsulters with B3S compared with healthy controls.
   Google Scholar
• Akehurst PL, Brazier JE, Mathers N etal Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. PharmacoEconomics 20(7), 455–462 (2002).
   PubMed Web of Science ®Google Scholar
• •Well-performed study that incorporates both HRQOL and related costs in IBS patients in primary care.
   Google Scholar
• Stewart AL, Greenfield S, Hays RD eta]. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JA/V/A 262(7), 907–913 (1989).
   Google Scholar
• ••Landmark study dealing with the effects ofvarious chronic disorders on daily living.
   Google Scholar
• Ware JE Jr, Sherbourne CD. The MOS 36- item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6), 473–483 (1992).
   Google Scholar
• ••Important paper describing the SF-36.
   Google Scholar
• McHorney CA, Ware JE Jr, Rogers W Raczek AE, Lu JE The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med. Care 30(5 Suppl), M5253-265 (1992).
   Google Scholar
• McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med. Care 31(3), 247–263. (1993).
   Google Scholar
• Koloski NA, Talley NJ, Boyce PM. The impact of functional gastrointestinal disorders on quality of life. Am. J. Castroenterol. 95(1), 67–71 (2000).
   Google Scholar
• Simren M, Mänsson A, Langkilde AM et al Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 63(2), 108–115 (2001).
   PubMed Web of Science ®Google Scholar
• Fass R, Fullerton S, Naliboff B, Hirsh T, Mayer EA. Sexual dysfunction in patients with irritable bowel syndrome and non-ulcer dyspepsia. Digestion 59(1), 79–85 (1998).
   PubMed Web of Science ®Google Scholar
• Elsenbruch S, Harnish MJ, On WC. Subjective and objective sleep quality in irritable bowel syndrome. Am. J. Castroenterol. 94(9), 2447–2452 (1999).
   Google Scholar
• Drossman DA, Whitehead WE, Toner BB etal. What determines severity among patients with painful functional bowel disorders? Am. J. Castroenterol. 95(4), 974–980 (2000).
   Google Scholar
• Drossman DA, Patrick DL, Whitehead WE etal. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am. J. Castroenterol. 95(4), 999–1007 (2000).
   Google Scholar
• Bergner M, Bobbitt RA, Carter VVB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med. Care 19(8), 787–805 (1981).
   PubMed Web of Science ®Google Scholar
• •Paper describing the important generic HRQOL instrument, the SIP
   Google Scholar
• Bergner M, Bobbitt RA, Pollard WE, Martin DP, Gilson BS. The Sickness Impact Profile: validation of a health status measure. Med. Care 14(1), 57–67 (1976).
   Google Scholar
• Pollard WE, Bobbitt RA, Bergner M, Martin DP, Gilson BS. The Sickness Impact Profile: reliability of a health status measure. Med. Care 14(2), 146–155 (1976).
   Google Scholar
• Dupuy HJ. The Psychological General Well-being (PGVVB) index. In: Assessment of Quality of Life in Clinical Blab of Cardiovascular Therapies. Wenger NK, Mattson ME, Furberg CF, Elinson J (Eds). Le Jacq Publishing Inc., CT, USA, 170–183 (1984).•Description of the PGVVB.
   Google Scholar
• Dimenäs E, Glise H, Hallerback B, Hernqvist H, Svedlund J, Wiklund I. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Land Castroenterol. 28(8), 681–687 (1993).
   Google Scholar
• Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Land Castroenterol 30(11), 1046–1052 (1995).
   Google Scholar
• Talley NJ, Meineche-Schmidt V, Pare P etal. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol The]: 12(11), 1055–1065 (1998).
   PubMed Web of Science ®Google Scholar
• Havelund T, Lind T, Wiklund I etal. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am. J. Castroenterol. 94(7), 1782–1789 (1999).
   Google Scholar
• Simrén M, Abrahamsson H, Svedlund J, Björnsson ES. Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand. I Gastroenterol. 36(5), 545–552 (2001).
   Google Scholar
• •Study comparing patients with IBS in primary and secondary care.
   Google Scholar
• Simrén M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Björnsson E Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am.j Gastmenterol. 97(2), 389–396 (2002).
   Web of Science ®Google Scholar
• •Importance of IBS-like symptoms in patients with inflammatory bowel disease and its impact on HRQOL and psychological symptoms (or vice versa) is often neglected.
   Google Scholar
• Glia A, Lindberg G. Quality of life in patients with different types of functional constipation. Land. j Gastmenterol. 32(11), 1083–1089 (1997).
   Web of Science ®Google Scholar
• Yacavone RF, Locke GR 3rd, Provenzale DT, Eisen GM. Quality of life measurement in gastroenterology: what is available? Am..j Gastroenterol. 96(2), 285–297 (2001).
   Google Scholar
• •Easy-to-understand overview of HRQOL measures in gastroenterology.
   Google Scholar
• Dimends E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand. I Gastroenteml (Suppl.) 221,8–13 (1996).
   Google Scholar
• Strid H, Simren M, Johansson AC, Svedlund J, Samuelsson 0, Bjömsson ES. The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrol Dial. Tiarisplant 17(8), 1434–1439 (2002).
   Google Scholar
• Fletcher AE, Chester PC, Hawkins CM, Latham AN, Pike LA, Bulpitt CJ. The effects of verapamil and propranolol on quality of life in hypertension. J. Hum Hypertens. 3(2), 125–130 (1989).
   PubMed Web of Science ®Google Scholar
• Nissinen A, Wildund I, Lahti T et al. Anti-anginal therapy and quality of life. A comparison of the effects of transdermal nitroglycerin and long-acting oral nitrates. Gun. Epidemiol. 44(9), 989–997 (1991).
   Google Scholar
• Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am. I Obstet. Gynecol. 168(3 Pt 1), 824–830 (1993).
   Google Scholar
• Irvine EJ. The quality of quality of life. Gut. 44(4), 450–451 (1999).
   Google Scholar
• •Important point-of-view in the development of several new disease-specific HRQOL measures in functional GI disorders.
   Google Scholar
• Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Aliment Pharmacol Ther. 11(3), 547–552 (1997).
   Google Scholar
• •Initial validation of the IBSQOL.
   Google Scholar
• Watson ME, Lacey L, Kong S eta]. Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome. Am. J. Gastroenterol 96(2), 455–459 (2001).
   Google Scholar
• •Paper describing the effects of alosetron on HRQOL in two large and well-performed trials.
   Google Scholar
• Chassany 0, Bergmann JE Quality of life in irritable bowel syndrome, effect of therapy. Eur.j Surg. Suppl. 583,81–86 (1998).
   Google Scholar
• Chassany 0, Marquis P, Scherrer B eta]. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut 44 (4), 527–533 (1999) .
   Google Scholar
• •Initial validation of the FDDQL.
   Google Scholar
• Wong E, Guyatt GH, Cook DJ, Griffith LE, Irvine EJ. Development of a questionnaire to measure quality of life in patients with irritable bowel syndrome. FIR: Surg. Suppl. 583,50–56 (1998).
   Google Scholar
• Groll D, Vanner SJ, Depew WT et al. The IBS-36: a new quality of life measure for irritable bowel syndrome. Am J. Gastroenterol. 97(4), 962–971 (2002).
   Google Scholar
• Poitras MR, Verrier P, So C, Paquet S, Bouin M, Poitras P Group counseling psychotherapy for patients with functional gastrointestinal disorders: development of new measures for symptom severity and quality of life. Mg. Dis. Sri. 47(6), 1297–1307 (2002).
   Google Scholar
• Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol The]: 11(2), 395–402 (1997).
   PubMed Web of Science ®Google Scholar
• Svedlund J, Sjödin I, Dotevall G. GSRS — a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig. Dis. Sri. 33(2), 129–134 (1988).
   Google Scholar
• Drossman DA. Review article: an integrated approach to the irritable bowel syndrome. Aliment Pharmacol The]: 13\(Suppl. 2), 3–14 (1999).
   Google Scholar
• •Nice paper describing the so-called biopsychosocial model of B3S. 70Corney RII, Stanton R. Physical symptom severity, psychological and social dysfunction in a series of out-patients with irritable bowel syndrome. J. PTchosom. Res. 34(5), 483–491 (1990).
   Google Scholar
• Lydiard RB, Fossey MD, Marsh W Ballenger JC. Prevalence of psychiatric disorders in patients with irritable bowel syndrome. PTchosomatics 34 (3), 229–234 (1993).
   PubMed Web of Science ®Google Scholar
• Svedlund J, Sjödin I, Dotevall G, Gillberg R. Upper gastrointestinal and mental symptoms in the irritable bowel syndrome. Land .j Gastroenterol. 20(5), 595–601 (1985).
   Web of Science ®Google Scholar
• Beck AT, Ward CH, Mendelson M. An inventory for measuring depression. Arch. Gen. PTchiatry6, 561–571 (1961).
   Web of Science ®Google Scholar
• Zignond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Land 67(6), 361–370 (1983).
   PubMed Web of Science ®Google Scholar
• Spielberger CD. Manual for the State- Trait Anxiety Inventory (Form Y). Consulting Psychologists Press Inc., CA, USA (1983).
   Google Scholar
• Derogatis LR, Rickels K, Rock AF. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. Br. J. PTchiatry128,280–289 (1976).
   Google Scholar
• Whorwell PJ, McCallum M, Creed FH, Roberts CT Non-colonic features of irritable bowel syndrome. Gut 27(1), 37–40 (1986).
   PubMed Web of Science ®Google Scholar
• •Paper describing the often difficult extracolonic features of IBS.
   Google Scholar
• Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WE Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin. Infect. as 18\(Suppl. 1), S79-83 (1994).
   Google Scholar
• Prince MI, James OFW, Holland NP, Jones DEJ. Validation of a fatigue impact score in primary binary cirrhosis: towards a standard for clinical and trial use. J. Hepatol. 32, 368–373 (2000).
   PubMed Web of Science ®Google Scholar
• Payne A, Blanchard EB. A controlled comparison of cognitive therapy and self-help support groups in the treatment of irritable bowel syndrome. J. Consult. Clin. PTchol. 63(5), 779–786 (1995).
   Google Scholar
• Toner BB, Stucldess N, Ali A, Downie F, Emmott S, Akman D. The development of a cognitive scale for functional bowel disorders. PTchosom. Med 60(4), 492–497 (1998).
   PubMed Web of Science ®Google Scholar
• •Promising tool for assessing cognitive functioning in functional bowel disorders.
   Google Scholar
• Toner BB, Segal ZV, Emmott S etal. Cognitive—behavioral group therapy for patients with irritable bowel syndrome. Int. J. Group flychother 48(2), 215–243 (1998).
   Google Scholar
• Thompson WG, Creed F, Drossman DA, Heaton KW, Mazzaca G. Functional Bowel Disease and Functional Abdominal Pain. Gastmenterol. Inter 5(2), 75–91 (1992).
   Google Scholar
• •ROME I criteria.
   Google Scholar
• Irvine EJ, Ferrazzi S, Pare P, Thompson WG, Rance L. Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. Am. Gastroenterol. 97(8), 1986–1993 (2002).
   Google Scholar
• Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. CIM Thor. 24(4), 675–89 (2002).
   Google Scholar
• Camilleri M, Williams DE. Economic burden of irritable bowel syndrome. Proposed strategies to control expenditures. PharmacoEconomics 17(4), 331–338 (2000).
   PubMed Web of Science ®Google Scholar
• van der Horst HE, van Dulmen AM, Schellevis FG, van Eijk JT, Fennis JF, Bleijenberg G. Do patients with irritable bowel syndrome in primary care really differ from out-patients with irritable bowel syndrome? Gut 41(5), 669–674 (1997).
   Google Scholar
• •Comparison between primary-care patients and hospital outpatients with IBS.
   Google Scholar
• Drossman DA, McKee DC, Sandler RS et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 95 (3), 701–708 (1988).
   PubMed Web of Science ®Google Scholar
• ••Landmark paper describing differences between patients with B3S and people in society with B3S not seeking healthcare.
   Google Scholar
• Manning AP, Thompson WG, Heaton KVV, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med. J. 2(6138), 653–654 (1978).
   Google Scholar
• ••Very important paper trying to achieve apositive diagnosis of IBS.
   Google Scholar
• Mearin F, Badia X, Balboa A etal. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Land. j Gastroenterol. 36(11), 1155–1161 (2001).
   Google Scholar
• Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ 3rd. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am. J. Gastroenterol. 95(10), 2816–2824 (2000).
   Google Scholar
• Badia X, Mearin F, Balboa A et a/. Burden of illness in irritable bowel syndrome comparing Rome land Rome II criteria. PhannacoEconomics20(11), 749–758 (2002).
   PubMed Web of Science ®Google Scholar
• •Paper that emphasizes the importance of how B3S is defined, when interpreting HRQOL (and other?) studies.
   Google Scholar
• Chassany 0, Sagnier P, Marquis P, Fullerton S, Aaronson N. Patient-reported outcomes: The example of health-related quality of life — a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inform J. 36,209-238 (2002).
   Google Scholar
• •Guidelines for HRQOL evaluation in treatment trials.
   Google Scholar
• Revicki DA, Osoba D, Fairdough D etal. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qua]. Life Res. 9(8), 887–900 (2000).
   Google Scholar
• •Guidelines for HRQOL evaluation in treatment trials.
   Google Scholar
• Santanello NC, Baker D, Cappelleri JC etal. Regulatory issues for health-related quality of life — PhRMA Health Outcomes Committee workshop, 1999. Value Health 5(1), 14–25 (2002).
   Google Scholar
• •Guidelines for HRQOL evaluation in treatment trials.
   Google Scholar
• Mathias JR, Clench MET, Abell TL etal. Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease: a double-blind, placebo-controlled, randomized study. Dig. Dir. Li. 43(6), 1347–1355 (1998).
   Google Scholar
• Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet 355(9209), 1035–1040 (2000).
   PubMed Web of Science ®Google Scholar
• Thompson CA. Alosetron withdrawn from market. Am.j Health Syst. Pharm. 58(1), 13 (2001).
   Google Scholar
• Watson ME. Minimum meaningful difference scores for the irritable bowel syndrome quality of life questionnaire (IBSQOL). Value Health 3,54–55 (2000).
   Google Scholar
• Dapoigny M, Abitbol JL, Fraitag B. Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose—response study. Dig. Dir. Li. 40(10), 2244–2249 (1995).
   Google Scholar
• Gonsalkorale WM, Houghton LA, Whorwell PJ. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness. Am. Gastroenterol. 97(4), 954–961 (2002).
   Google Scholar
• •Clinical audit of the first 250 patients treated with hypnotherapy in a specialized center.
   Google Scholar
• Houghton LA, Heyman DJ, Whorwell PJ. Symptomatology, quality of life and economic features of irritable bowel syndrome-the effect of hypnotherapy. Aliment Pharmacol Thor. 10(1), 91–95 (1996).
   PubMed Web of Science ®Google Scholar
• Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Painl (3), 277–299 (1975).
   Google Scholar